AZRX AzurRx BioPharma Inc.

-0.02  -1%
Previous Close 3.28
Open 3.27
Price To book 7.95
Market Cap 36617774
Shares 11,232,446
Volume 24,570
Short Ratio 0.48
Av. Daily Volume 62,690

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2a data from first six patients released September 27, 2017. CFA improvement of 21% noted in highest dose.
Exocrine pancreatic insufficiency (EPI) caused by chronic pancreatitis (CP)